MCP-1 binding nucleic acids

US9670491B2 · kind B2 · utility

Assignee

• NOXXON Pharma AG · DE

Inventors

• Werner Purschke · Berlin, DE
• Florian Jarosch · Berlin, DE
• Dirk Eulberg · Berlin, DE
• Sven Klussmann · Berlin, DE
• Klaus Buchner · Schaffhausen, CH
• Christian Maasch · Berlin, DE

Key dates

• Filing date: Apr 6, 2014
• Grant date: Jun 6, 2017
• Expiry date: Apr 6, 2034

Classification

• Technology area (CPC C): Chemistry; Metallurgy
• CPC primary: C12N2310/351
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

The present invention is related to a nucleic acid, preferably binding to MCP-1, selected from the group consisting of Type 1A nucleic acids, type 1B nucleic acids, Type 2 nucleic acids, Type 3 nucleic acids, Type 4 nucleic acids and nucleic acids comprising SEQ ID NOs:87-115